Home/StemSight/Tanja Ilmarinen

TI

Tanja Ilmarinen

Chief Scientific Officer (CSO)

Therapeutic Areas

Ophthalmology Corneal Blindness

StemSight Pipeline

Drug	Indication	Phase
iPSC-derived Limbal Stem Cell Therapy	Limbal Stem Cell Deficiency (LSCD) leading to corneal blindness	Pre-clinical

Leadership Team at StemSight

Laura Koivusalo

Chief Commercial Officer (CCO)

Founding Scientist / Professor

View full StemSight profile